© MND Scotland 2025
Home > News
Read real stories from people affected by MND, get inspired by the incredible ways people are supporting our cause and hear more about the latest advancements in research, care and support.
There has been ongoing coverage in the UK media of an early-stage compound, ellorarxine, that targets the retinoic acid receptor (RAR).